🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10581+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10581 recruiting trials

Phase 2RecruitingNCT06800651

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

👨‍⚕️ Hong Zhang, Ph.D, Peking University First Hospital📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06651489

Efficacy of Guselkumab in Treating Hailey Hailey Disease

👨‍⚕️ Keith Choate, MD, PhD, Yale University📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06869551

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 47 sites📅 Started Mar 2025View details ↗
RecruitingNCT06924463

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

🏥 Lille University📍 1 site📅 Started Mar 2025View details ↗
NARecruitingNCT07512778

IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome

👨‍⚕️ Suk Min Seo, MD, PhD, The Catholic University of Korea Eunpyeong St. Mary's Hospital📍 1 site📅 Started Mar 2025View details ↗
EARLY_Phase 1RecruitingNCT07104201

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

🏥 Xijing Hospital of Digestive Diseases📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06868290

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 31 sites📅 Started Mar 2025View details ↗
RecruitingNCT06887907

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient

👨‍⚕️ Pierre COUGOUL, MD, University Hospital, Toulouse📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06792695

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

🏥 AstraZeneca📍 76 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06662058

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

👨‍⚕️ Nicole C Schmitt, MD, FACS, Emory University Hospital/Winship Cancer Institute📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06476132

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

👨‍⚕️ Scott M. Palmer, M.D., M.H.S., Duke University Medical Center: Transplantation📍 10 sites📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT03816319

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

👨‍⚕️ Guillaume Richard-Carpentier, University Health Network Princess Margaret Cancer Center LAO📍 5 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06551272

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

👨‍⚕️ Héloise BOURIEN, Dr, Centre de lutte contre le cancer Eugène Marquis📍 6 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06192160

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

👨‍⚕️ Radojka Savic, PharmD, PhD, University of California📍 28 sites📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06940739

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

👨‍⚕️ Iovance Biotherapeutics Study Team, Iovance Biotherapeutics📍 4 sites📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06668181

An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

👨‍⚕️ UCB Cares, 001 844 599 2273📍 23 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06627270

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

👨‍⚕️ Natalie Silver, MD, Case Comprehensive Cancer Center, Cleveland Clinic Foundation📍 1 site📅 Started Mar 2025View details ↗
Phase 2, PHASE3RecruitingNCT06855810

Newly-diagnosed Pediatric T-cell ALL Protocol

👨‍⚕️ Xiaofan Zhu, MD, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC📍 27 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06773910

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

👨‍⚕️ Melissa Johnson, MD, SCRI Development Innovations, LLC📍 30 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06730126

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

👨‍⚕️ V. Koneti Rao, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 3 sites📅 Started Mar 2025View details ↗
← PreviousPage 137 of 530Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →